Insider · CIK 0001880129

KENNEY CHRISTOPHER JOHN

Reports to the SEC for 1 company · BURNABY

sec.gov

Transactions

Companies

Filings

CIK

0001880129

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-28	XENEXenon Pharmaceuticals Inc.S Sale	Chief Medical Officer	SSale	−6,368 sh	$60.17	−$383K	702
2026-08-28	XENEXenon Pharmaceuticals Inc.S Sale	Chief Medical Officer	SSale	−700 sh	$60.98	−$42.7K	2
2026-03-13	XENEXenon Pharmaceuticals Inc.S Sale	Chief Medical Officer	SSale	−1,410 sh	$55.23	−$77.9K	7,069
2026-03-12	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,750 sh	—	—	8,479
2026-03-12	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,750 sh	—	—	11,250
2026-03-10	XENEXenon Pharmaceuticals Inc.S Sale	Chief Medical Officer	SSale	−2,771 sh	$60.11	−$167K	4,729
2026-03-09	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+7,500 sh	—	—	7,500
2026-03-09	XENEXenon Pharmaceuticals Inc. · Performance Share UnitsA Award	Chief Medical Officer	AAward	+7,500 sh	—	—	7,500
2026-03-09	XENEXenon Pharmaceuticals Inc. · Performance Share UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−7,500 sh	—	—	0
2026-01-09	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Chief Medical Officer	AAward	+100K sh	—	—	100,000
2026-01-09	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Chief Medical Officer	AAward	+20K sh	—	—	20,000
2025-03-12	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Chief Medical Officer	AAward	+80K sh	—	—	80,000
2025-03-12	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Chief Medical Officer	AAward	+15K sh	—	—	15,000
2024-03-11	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+100K sh	—	—	100,000
2023-03-24	XENEXenon Pharmaceuticals Inc.S Sale	Chief Medical Officer	SSale	−700 sh	$35.01	−$24.5K	0
2023-03-10	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+120K sh	—	—	120,000
2022-03-10	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+125K sh	—	—	125,000
2022-01-21	XENEXenon Pharmaceuticals Inc.P Purchase	Chief Medical Officer	PPurchase	+700 sh	$28.81	+$20.2K	700
2021-08-23	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Aug 314
KENNEY CHRISTOPHER JOHN0001193125-26-377309
SEC(opens sec.gov)
Mar 134
KENNEY CHRISTOPHER JOHN0001193125-26-106727
SEC(opens sec.gov)
Mar 114
KENNEY CHRISTOPHER JOHN0001193125-26-102669
SEC(opens sec.gov)
Jan 94
KENNEY CHRISTOPHER JOHN0001193125-26-009238
SEC(opens sec.gov)
Mar 134
KENNEY CHRISTOPHER JOHN0000950170-25-039021
SEC(opens sec.gov)
Mar 124
KENNEY CHRISTOPHER JOHN0000950170-24-030239
SEC(opens sec.gov)
Mar 244
KENNEY CHRISTOPHER JOHN0001209191-23-021136
SEC(opens sec.gov)
Mar 144
KENNEY CHRISTOPHER JOHN0001209191-23-018476
SEC(opens sec.gov)
Mar 144
KENNEY CHRISTOPHER JOHN0001209191-22-018449
SEC(opens sec.gov)
Jan 214
KENNEY CHRISTOPHER JOHN0001209191-22-004460
SEC(opens sec.gov)
Aug 254
KENNEY CHRISTOPHER JOHN0001209191-21-053304
SEC(opens sec.gov)

Companies

Xenon Pharmaceuticals Inc.Chief Medical OfficerXENE

Address

3650 GILMORE WAY

BURNABY, V5G 4W8